New Brunswick Scientific Appoints William Murphy to Board
12 Février 2007 - 7:07PM
PR Newswire (US)
EDISON, N.J., Feb. 12 /PRNewswire-FirstCall/ -- New Brunswick
Scientific Co., Inc. (NBS) (NASDAQ:NBSC), a leading provider of a
comprehensive line of research equipment and scientific
instrumentation for use in the life science industry, announced the
election of William J. Murphy to its Board of Directors, effective
February 9, 2007. Murphy, 62, a certified public accountant with
extensive financial experience, will serve on the Company's Audit
Committee and has been designated its Financial Expert. From 1997
to 2005, Murphy held several positions with Computer Horizons
Corp., a Nasdaq-listed information services company, initially as
executive vice president and chief financial officer, and from
March 2003 until October 2005, as president and chief executive
officer. From 1980 to 1997, he was employed by the accounting firm
of Grant Thornton LLP, where he was most recently partner in charge
of its New Jersey Practice. Prior to joining Grant Thornton, he
served as a senior audit manager for accounting firm Price
Waterhouse. Murphy is a member of the New Jersey State Society of
CPAs, the American Institute of Certified Public Accountants and
the Financial Executives International. He also serves on the board
of directors of the Commerce and Industry Association of New
Jersey, a not-for-profit pro-business organization, and NYSE-listed
Bradley Pharmaceuticals, Inc. This appointment of Murphy as
independent director to the NBS Board brings the total number of
directors to nine, returning the Company to compliance with Nasdaq
Marketplace Rule 4350(d)(2), requiring that the Audit Committee be
composed of at least three independent directors. The Board vacancy
was created by the untimely death of director Joel Jaffe on October
8, 2006. To be added to New Brunswick Scientific's e-mail
distribution list, please click on the link below:
http://www.clearperspectivegroup.com/clearsite/nbsc/emailoptin.html
About New Brunswick Scientific New Brunswick Scientific Co., Inc.,
is a leading global innovator providing a comprehensive line of
equipment and instrumentation for the life science industry. The
Company's products are used in the creation, maintenance and
control of physical and biochemical environments required for the
growth, detection and storage of microorganisms for medical,
biological and chemical applications, environmental research and
commercial products. Established in 1946, the Company is
headquartered in Edison, New Jersey, with sales and distribution
facilities located in the United States, Europe and Asia. For more
information, please visit http://www.nbsc.com/ . This document
contains "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995. Forward-looking
statements may be identified by words such as "expects,"
"anticipates," "intends," "plans," "believes," "seeks,"
"estimates," "will" or words of similar meaning and include, but
are not limited to, statements about the expected future business
and financial performance of the Company. The forward-looking
statements include a number of risks and uncertainties, which are
detailed in Part I, Item 1A, "Risk Factors" of our Annual Report on
Form 10-K for the year ended December 31, 2005, and other risk
factors identified herein or from time to time in our periodic
filings with the Securities and Exchange Commission.
Forward-looking statements are based on management's current
expectations and assumptions, which are inherently subject to
uncertainties, risks and changes in circumstances that are
difficult to predict. Actual outcomes and results may differ
materially from these expectations and assumptions due to changes
in global political, economic, business, competitive, market,
regulatory and other factors. The Company undertakes no obligation
to publicly update or review any forward-looking information,
whether as a result of new information, future developments or
otherwise. DATASOURCE: New Brunswick Scientific Co., Inc. CONTACT:
Investor Contacts: Thomas Bocchino, Vice President, Finance and
Treasurer of New Brunswick Scientific Co., Inc., +1-732-650-2500, ;
or Matthew J. Dennis, CFA, NBS Investor Relations, Clear
Perspective Group, LLC, +1-732-226-3030, Web site:
http://www.nbsc.com/
Copyright
New Brunswick Scientific (NASDAQ:NBSC)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
New Brunswick Scientific (NASDAQ:NBSC)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024